Antibody News and Research RSS Feed - Antibody News and Research

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.
Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments. [More]
Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. [More]
Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes. [More]
Antibody drug offers new therapeutic approach for treating AML

Antibody drug offers new therapeutic approach for treating AML

An antibody drug that targets a surface marker on cancer stem cells could offer a promising new therapeutic approach for treating acute myeloid leukemia (AML), a form of blood cancer that affects an estimated 50,000 people in Saudi Arabia. [More]
New Chromatrap ChIP-validated antibodies now available for mammalian epigenetic research

New Chromatrap ChIP-validated antibodies now available for mammalian epigenetic research

Chromatrap announces that seven further popular antibodies have been validated for use in chromatin immunoprecipitation (ChIP) assays by their UK-based research team. [More]
Scientist develops way to detect BoNT in biological samples

Scientist develops way to detect BoNT in biological samples

Many know Botox as a trendy way to get rid of wrinkles, but the popular drug — made from botulinum neurotoxin (BoNT) — can do more than just fill lines. [More]
Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

Modern medicine is taking a new look at an ancient remedy for severe diarrhea as a novel approach to treat a serious gastrointestinal infection. [More]
Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

Experts receive $5.2 million NIH grant to develop affordable test for diagnosing Chagas disease

An international team of researchers led by infectious disease experts at the University of Georgia has received $5.2 million from the National Institutes of Health to develop a more accurate, affordable diagnostic test for Chagas disease, a parasitic infection that kills more than 50,000 people each year in Central and South America. [More]
BBI Solutions introduces novel conjugate blocking technology to improve performance of lateral flow immunoassays

BBI Solutions introduces novel conjugate blocking technology to improve performance of lateral flow immunoassays

BBI Solutions has launched Morffi, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September. [More]
AMSBIO creates new 24-page guide for researchers using heparan sulfate antibodies

AMSBIO creates new 24-page guide for researchers using heparan sulfate antibodies

AMSBIO has produced a new 24-page guide that brings together applications, protocols, results and citations to provide an informative resource for researchers using heparan sulfate antibodies. [More]
Guidelines for staying healthy during flu season

Guidelines for staying healthy during flu season

The American Academy of Pediatrics updated its annual influenza (flu) season guidelines, withdrawing the child-friendly nasal flu vaccine, FluMist, this year. [More]
Chromatrap reports benefits of using ChIP-seq kit for histone methylation applications

Chromatrap reports benefits of using ChIP-seq kit for histone methylation applications

Chromatrap reports on the advantages of using its Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits for histone methylation applications. [More]
Food intolerance testing: an interview with Dr Gill Hart

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances. [More]
Study shows possibility to achieve immunological antibody memory with mucosal vaccination

Study shows possibility to achieve immunological antibody memory with mucosal vaccination

If a vaccine is to protect the intestines and other mucous membranes in the body, it also needs to be given through the mucosa, for example as a nasal spray or a liquid that is drunk. [More]
Discovery of immune antibody could lead to development of improved influenza vaccines

Discovery of immune antibody could lead to development of improved influenza vaccines

Dana-Farber Cancer Institute investigators report they have discovered a type of immune antibody that can rapidly evolve to neutralize a wide array of influenza virus strains - including those the body hasn't yet encountered. [More]
BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system. [More]
Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

Study shows holes in HIV's protective glycan shield could be vital in designing vaccine candidates

A new study from scientists at The Scripps Research Institute shows that "holes" in HIV's defensive sugar shield could be important in designing an HIV vaccine. [More]
TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

TSRI, IAVI scientists reveal new reductionist vaccine strategy to fight against HIV

A series of new studies led by scientists at The Scripps Research Institute and the International AIDS Vaccine Initiative describe a potential vaccination strategy to jump-start the selection and evolution of broadly effective antibodies to prevent HIV infection. [More]
Gut microbiota may play role in influencing food allergies

Gut microbiota may play role in influencing food allergies

Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich (TUM) have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens. [More]
Combinational analysis of FISH and IHC detects NSCLC patients with rare ALK fusions

Combinational analysis of FISH and IHC detects NSCLC patients with rare ALK fusions

The combined use of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) identified non-small cell lung cancer (NSCLC) patients with rare or novel anaplastic lymphoma kinase (ALK) gene rearrangements, not otherwise identified by FISH alone, that showed response to crizotinib treatment. [More]
Advertisement
Advertisement